{"filing":{"accession_number":"0001193125-26-315151","cik":"0000860730","ticker":"HCA","company_name":"HCA Healthcare, Inc.","form":"8-K","filing_date":"2026-07-24","report_date":"2026-07-24","primary_document":"hca-20260724.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/hca-20260724.htm"},"events":[{"id":20307,"run_id":18284,"accession_number":"0001193125-26-315151","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"HCA Healthcare issued a press release on July 24, 2026 announcing its second quarter 2026 financial results, including revenues of $20.230 billion, net income of $1.699 billion, and diluted EPS of $7.62, along with updated full-year 2026 guidance.","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19634,"accession_number":"0001193125-26-315151","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"HCA Healthcare issued a press release on July 24, 2026 announcing its second quarter 2026 financial results, including revenues of $20.230 billion, net income of $1.699 billion, and diluted EPS of $7.62. The filing explicitly states the Item 2.02 disclosure is the press release announcing \"results of operations for the second quarter ended June 30, 2026,\" which is the classic earnings release disclosure. The press release includes detailed quarterly metrics, six-month results, balance sheet information, and updated full-year 2026 guidance, all hallmarks of a quarterly earnings announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"","ticker":null,"filing_date":""},{"id":19635,"accession_number":"0001193125-26-315151","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"HCA Healthcare issued a press release on July 24, 2026 announcing its financial and operating results for the second quarter ended June 30, 2026. The disclosure includes key metrics (revenues of $20.230 billion, net income of $1.699 billion, diluted EPS of $7.62), updated 2026 guidance, and detailed commentary on operational performance. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure) as Exhibit 99.1, which is the typical vehicle for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":20308,"run_id":18284,"accession_number":"0001193125-26-315151","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"HCA Healthcare's Board of Directors declared a quarterly cash dividend of $0.78 per share, payable September 30, 2026 to stockholders of record as of September 16, 2026.","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19636,"accession_number":"0001193125-26-315151","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"HCA Healthcare announced a quarterly cash dividend of $0.78 per share declared by the Board of Directors, payable September 30, 2026 to stockholders of record as of September 16, 2026. This is a routine but material capital allocation decision disclosed in Item 8.01 and confirmed in the earnings release. Dividend declarations are material to investors assessing shareholder returns and capital allocation policy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19634,"accession_number":"0001193125-26-315151","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"HCA Healthcare issued a press release on July 24, 2026 announcing its second quarter 2026 financial results, including revenues of $20.230 billion, net income of $1.699 billion, and diluted EPS of $7.62. The filing explicitly states the Item 2.02 disclosure is the press release announcing \"results of operations for the second quarter ended June 30, 2026,\" which is the classic earnings release disclosure. The press release includes detailed quarterly metrics, six-month results, balance sheet information, and updated full-year 2026 guidance, all hallmarks of a quarterly earnings announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-24"},{"id":19635,"accession_number":"0001193125-26-315151","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"HCA Healthcare issued a press release on July 24, 2026 announcing its financial and operating results for the second quarter ended June 30, 2026. The disclosure includes key metrics (revenues of $20.230 billion, net income of $1.699 billion, diluted EPS of $7.62), updated 2026 guidance, and detailed commentary on operational performance. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure) as Exhibit 99.1, which is the typical vehicle for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-24"},{"id":19636,"accession_number":"0001193125-26-315151","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"HCA Healthcare announced a quarterly cash dividend of $0.78 per share declared by the Board of Directors, payable September 30, 2026 to stockholders of record as of September 16, 2026. This is a routine but material capital allocation decision disclosed in Item 8.01 and confirmed in the earnings release. Dividend declarations are material to investors assessing shareholder returns and capital allocation policy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T11:46:49.841120+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-24"}]}